Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
456,920
-
Share change
-
+5,053
-
Total reported value
-
$1,849,000
-
Price per share
-
$4.04
-
Number of holders
-
10
-
Value change
-
-$8,044
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2021
As of 31 Dec 2021 Lexaria Bioscience Corp. - COM NEW (LEXX) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 456,920 shares of stock of the company.
Largest 10 holders included Invenomic Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, UBS Group AG, Edge Wealth Management LLC, MD Financial Management Inc., ADVISOR GROUP HOLDINGS, INC., Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and ROYAL BANK OF CANADA.
This table shows 10 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.